Company profile: Eurofins
1.1 - Company Overview
Company description
- Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
Products and services
- Environmental Testing: Eurofins delivers laboratory-grade assessments of water, air, soil, waste, and related products, testing to evaluate their effects on human health and environmental quality across diverse matrices
- Microbiological Testing: Eurofins performs industrial-grade microbiological analyses for various industries, ensuring product safety and compliance by conducting targeted testing
- Clinical Diagnostics: Eurofins offers clinical-grade diagnostics, spanning sample collection, laboratory testing, and medical counseling as an integrated service
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Eurofins
Inotiv
HQ: United States
Website
- Description: Provider of biopharmaceutical analytical, reproductive toxicology, and medical device testing, offering in vivo preclinical efficacy and toxicity, DMPK method development and bioanalysis, genetic toxicology, histology, and anatomical, clinical, and medical device pathology, plus consulting in DMPK data analysis, biomarker analysis, and bioequivalence to support biologic and small molecule drug development from discovery to First-in-Human.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inotiv company profile →
Amatsigroup
HQ: France
Website
- Description: Provider of GLP- and GMP-compliant CRO/CMO services for human and veterinary pharmaceutical product development, leveraging the expertise of renowned CROs/CMOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amatsigroup company profile →
Remus Pharmaceuticals
HQ: United States
Website
- Description: Provider of sterile liquid injectables and oral solid forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remus Pharmaceuticals company profile →
Velocity Clinical Research
HQ: United States
Website
- Description: Provider of clinical trial management; patient recruitment and retention; and in-house laboratory services to deliver high-quality clinical trial data. Offers technology solutions (VISION Recruit, VISION Engage) to streamline clinical trial processes and improve patient experiences, consumer product safety and efficacy testing, and sustainability initiatives to reduce environmental impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Velocity Clinical Research company profile →
FIS
HQ: Italy
Website
- Description: Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and intermediates, supporting clients from development to commercial production. Offers generic API development and manufacturing, veterinary CDMO, and specialized sterile manufacturing, micronization, lyophilization, and spray drying. Produces 100+ APIs across anticancer, steroids, psychotropics, and veterinary classes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FIS company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Eurofins
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Eurofins
2.2 - Growth funds investing in similar companies to Eurofins
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Eurofins
4.2 - Public trading comparable groups for Eurofins
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →